Juhyeon Lee

Dr. Lee is an exceptional medicinal chemist who has experience developing novel anticancer agents to target kinases, as well as novel anti-hepatitis C virus (HCV) agents and new PreQ1 riboswitch regulators.  She supports compound modeling, design, and synthesisalong with SAR analysis.